Extended Data Fig. 1: LIMIT correlates to effector immune genes across multiple cancer types.
From: LIMIT is an immunogenic lncRNA in cancer immunity and immunotherapy
a-l, Correlation of LIMIT with IFNG, MHC-I, or CD8 in human patients with sarcoma (SARC) (a-c), colon cancer (COAD) (d-f), breast cancer (BRCA) (g-i), and kidney cancer (KIRC) (j-l). P value by 2 sided linear regression. Source data are provided.
